Savient Pharmaceuticals, Inc. (SVNT) Misses Q2 Loss Views by 13c
Tweet
Share
E-mailGet Alerts SVNT Hot Sheet
Price: $40.05 --0%
Financial Fact:
Operating expenses: 19.89M
Today's EPS Names:
FRSB, DGICA, UXIN, More
Financial Fact:
Operating expenses: 19.89M
Today's EPS Names:
FRSB, DGICA, UXIN, More
Join SI Premium – FREE
Savient Pharmaceuticals, Inc. (NASDAQ: SVNT) reported Q2 EPS of ($0.43), $0.13 worse than the analyst estimate of ($0.30). Revenue for the quarter came in at $2 million versus the consensus estimate of $2.77 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Gilead Sciences (GILD) Misses Q1 EPS by 288c
- Kinsale Capital Group (KNSL) Tops Q1 EPS by 16c
- USCB Financial Holdings, Inc. (USCB) Tops Q1 EPS by 2c
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
